semaglutide compounding news november 2025 Drug compounders sue FDA over declaration ending Wegovy shortage Patients Cut Off From Cheaper

This article is educational only

The term GLP-1 agonist refers to a type of medication that medical professionals may prescribe to patients needing treatment for high blood glucose levels or who may need assistance with managing their weight

The compound remains in Phase 3 clinical trials, with multiple studies expected to report results throughout this year

These drugs work by mimicking GLP-1, a naturally occurring hormone made in the intestines

CrossRef Emerging DNA- and RNA-based therapeutic strategies in hepatocellular carcinoma: A molecular approach to precision medicine Zulfa Nooreen, Ankita Wal, Anjali Shukla, A

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management